Sun Pharmaceutical Industries, India’s largest drug maker by value, is
planning to raise Rs 12000 crore through qualified institutional
placement (QIP) route. In this regard, the company is seeking
shareholders’ approval at its 27th annual general meeting to be held by
the end of September. Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment